Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
lenalidomide 2.5 mg capsule, 14 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
carbimazole 5 mg tablet, 60 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
asciminib 40 mg tablet, 60 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
carbimazole 5 mg tablet, 30 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
carbimazole 5 mg tablet, 120 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
ropivacaine hydrochloride 200 mg/100 mL injection, 10 x 100 mL bags |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
darunavir 75 mg tablet, 480 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
thalidomide 150 mg capsule, 28 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
thalidomide 200 mg capsule, 28 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 15 mg/mL + cannabidiol 24 mg/mL oral oil, 30 mL |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol less than 1 mg/mL oral oil, 30 mL |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 24% + cannabidiol less than 0.1% bud, 10 g |
Is a |
False |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 28% + cannabidiol less than 0.1% bud, 10 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 28% + cannabidiol less than 0.1% bud, 9 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 30% + cannabidiol less than 0.1% bud, 9 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 22% + cannabidiol less than 1% bud, 15 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
methionine 500 mg capsule, 100 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
phenylephrine hydrochloride 10 mg tablet, 10 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
phenylephrine hydrochloride 10 mg tablet, 20 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 15% + cannabidiol less than 0.1% bud, 10 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
desloratadine 2.5 mg/5 mL oral liquid, 15 mL |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
desloratadine 2.5 mg/5 mL oral liquid, 50 mL |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
desloratadine 2.5 mg/5 mL oral liquid, 60 mL |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
desloratadine 2.5 mg/5 mL oral liquid, 100 mL |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
desloratadine 2.5 mg/5 mL oral liquid, 200 mL |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol less than 1% + cannabidiol 14% bud, 3 x 5 g sachets |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 22% + cannabidiol less than 1% bud, 10 g |
Is a |
False |
medicinal product pack |
Inferred relationship |
Some |
|
olanzapine 15 mg orally disintegrating tablet, 5 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
olanzapine 20 mg orally disintegrating tablet, 5 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
lidocaine hydrochloride 2% (40 mg/2 mL) injection, 5 x 2 mL ampoules |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
lidocaine hydrochloride 1% (20 mg/2 mL) injection, 5 x 2 mL ampoules |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
glycomacropeptide and essential amino acids with vitamins and minerals powder for oral liquid, 30 x 40 g sachets |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tafenoquine 50 mg dispersible tablet, 30 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
selumetinib 25 mg capsule, 60 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
selumetinib 10 mg capsule, 60 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
ponesimod 20 mg tablet, 28 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 2.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 15 mg/0.5 mL injection, 4 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 7.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 2.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 15 mg/0.5 mL injection, 2 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 7.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 10 mg/0.5 mL injection, 4 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 12.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 10 mg/0.5 mL injection, 2 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 12.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 5 mg/0.5 mL injection, 4 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tirzepatide 5 mg/0.5 mL injection, 2 x 0.5 mL pen devices |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
budesonide 32 microgram/actuation nasal spray, 3 x 120 actuations |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
budesonide 32 microgram/actuation nasal spray, 2 x 120 actuations |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tozinameran 15 microgram/0.3 mL + famtozinameran 15 microgram/0.3 mL injection, 195 x 2.25 mL vials |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tozinameran 15 microgram/0.3 mL + famtozinameran 15 microgram/0.3 mL injection, 10 x 2.25 mL vials |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
treosulfan 1 g injection, 5 vials |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
treosulfan 1 g injection, 1 vial |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
treosulfan 5 g injection, 1 vial |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
treosulfan 5 g injection, 5 vials |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
esmolol hydrochloride 100 mg/10 mL injection, 10 x 10 mL vials |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
amsacrine 75 mg/1.5 mL injection [6 x 1.5 mL vials] (&) inert substance diluent [6 x 13.5 mL vials], 1 pack |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
estetrol 14.2 mg + drospirenone 3 mg tablet [24] (&) inert substance tablet [4], 6 x 28 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
estetrol 14.2 mg + drospirenone 3 mg tablet [24] (&) inert substance tablet [4], 28 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
estetrol 14.2 mg + drospirenone 3 mg tablet [24] (&) inert substance tablet [4], 3 x 28 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
influenza quadrivalent geriatric vaccine 2023 injection, 5 x 0.7 mL syringes |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
influenza quadrivalent adjuvanted geriatric vaccine 2023 injection, 10 x 0.5 mL syringes |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
influenza quadrivalent adjuvanted geriatric vaccine 2023 injection, 0.5 mL syringe |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
elasomeran 25 microgram/0.5 mL + davesomeran 25 microgram/0.5 mL injection, 10 x 2.5 mL vials |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
influenza quadrivalent vaccine 2023 injection, 0.5 mL syringe |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
influenza quadrivalent vaccine 2023 injection, 10 x 0.5 mL syringes |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
influenza quadrivalent vaccine 2023 injection, 5 x 0.5 mL syringes |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
influenza quadrivalent cell based vaccine 2023 injection, 10 x 0.5 mL syringes |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
influenza quadrivalent cell based vaccine 2023 injection, 0.5 mL syringe |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
estradiol 10 microgram modified release pessary, 24 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tozinameran injection, 10 x 0.4 mL vials |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
tozinameran injection, 195 x 0.4 mL vials |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol less than 1% + cannabidiol 16% bud, 10 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 6% + cannabidiol 6% bud, 10 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 17% + cannabidiol less than 1% bud, 10 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 22% bud, 10 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 21% bud, 10 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 24% bud, 10 g |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
elasomeran 25 microgram/0.5 mL + davesomeran 25 microgram/0.5 mL injection, 10 x 0.5 mL syringes |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
dexamethasone phosphate 4 mg/mL injection, 25 x 1 mL ampoules |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
dexamethasone phosphate 4 mg/mL injection, 10 x 1 mL ampoules |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
esmolol hydrochloride 100 mg/10 mL injection, 10 x 10 mL ampoules |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
meningococcal A 10 microgram/0.5 mL + meningococcal C 10 microgram/0.5 mL + meningococcal W135 10 microgram/0.5 mL + meningococcal Y 10 microgram/0.5 mL conjugate vaccine injection, 0.5 mL vial |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
meningococcal A 10 microgram/0.5 mL + meningococcal C 10 microgram/0.5 mL + meningococcal W135 10 microgram/0.5 mL + meningococcal Y 10 microgram/0.5 mL conjugate vaccine injection, 10 x 0.5 mL vials |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
maribavir 200 mg tablet, 56 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
maribavir 200 mg tablet, 28 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
mesalazine 2 g modified release granules, 15 sachets |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
mesalazine 1 g modified release granules, 30 sachets |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
mesalazine 2 g modified release granules, 10 sachets |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
methadone hydrochloride 10 mg tablet, 10 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
naproxen 1 g modified release tablet, 7 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 25 mg/mL + cannabidiol 25 mg/mL oral oil, 50 mL |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
vosoritide 560 microgram injection [10 vials] (&) inert substance diluent [10 x 0.7 mL syringes], 1 pack |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 15 x 237 mL bottles |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
vosoritide 400 microgram injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
vosoritide 1.2 mg injection [10 vials] (&) inert substance diluent [10 x 0.6 mL syringes], 1 pack |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
upadacitinib 45 mg modified release tablet, 28 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|
upadacitinib 45 mg modified release tablet, 7 |
Is a |
True |
medicinal product pack |
Inferred relationship |
Some |
|